Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi Pasteur Set To Ship Japan’s First Foreign Hib Vaccine

This article was originally published in PharmAsia News

Executive Summary

The head of France-based Sanofi Pasteur said Japan's first foreign-made vaccine for hemophilus influenza type B is expected to be on the market by December. The drug is notable for being the first vaccine licensed by a multinational drug maker to be sold in Japan. Sanofi President Wayne Pisano said strict Japanese approval requirements had delayed the vaccine being allowed there even as it was available in other countries. The infectious disease affects children under 5 with meningitis and pneumonia. Japan expects to receive about 500,000 doses of the vaccine each year. The company make
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066895

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel